Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Testing the construct validity of real-world digital mobility outcomes in multiple sclerosis.
Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
From Molecular Mimicry to Clinical Laboratory: Longitudinal Measurement of EBNA1-Antibody Titers as a Diagnostic Biomarker of Multiple Sclerosis.
Transcriptomic profiling and structural characterization reveal UQCRC1 and COX4I1 as key mitochondrial regulators associated with oxidative stress in multiple sclerosis.
Disability and race in MS: Does socioeconomic disadvantage play a role?
Early injury-induced responses in the transected adult human sural nerve.
Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.
SGK1-mediated deficits in microglial phagocytosis drive pathological progression in amyotrophic lateral sclerosis.
Panax quinquefolius saponins promote remyelination via orchestrating HMGCS1-NPC1-MAL-mediated lipid metabolism and rebalancing JAK-STAT signaling in a cuprizone-induced demyelination model.
Diagnostic overshadowing in primary progressive multiple sclerosis with coexisting tethered cord syndrome and long-standing urological dysfunction: a case report and literature review.
Clinical Characteristics of Multiple Sclerosis and Association of MS Severity with Vitamin D Level in the Madinah Region of Saudi Arabia: A Cross-Sectional Study.
Global O-GlcNAcome Identifies O-GlcNAcylated Proteins Regulating Oligodendrocyte Precursor Cells Differentiation.
Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study.
Can speech reveal mental health status? A study of linguistic features across multiple samples of at-risk adults.
Tertiary lymphoid structures in neuroinflammation coordinate neuroimmune homeostasis and pathological progression.
Deep learning-based hybrid analysis for axonal regeneration and myelination in rat sciatic nerve.
[Clinical immunomodulatory effects of cannabinoids in autoimmune diseases in internal medicine : A literature review].
Clinical characteristics and prognosis of antibody-mediated autoimmune encephalitis: A single-center cohort study in Liuzhou, China.
Urinary tract infections, urosepsis, and multiple sclerosis disease modifying therapies: a disproportionality analysis of the FDA Adverse Event Reporting System.
Evidence of musculoskeletal pain sensitization in patients with multiple sclerosis: Case-control study.
Multiple sclerosis as an asynchronous neuroinflammatory system.
Genetically predicted association between immune cells and optic neuritis: evidence from a Mendelian randomization study.
Artificial intelligence for pediatric neuroimaging.
Unilateral facial flushing and anhidrosis: a case of idiopathic Harlequin syndrome with successful botulinum toxin treatment.
A mathematical model for inflammation and demyelination in multiple sclerosis.
Pages
« first
‹ previous
…
1044
1045
1046
1047
1048
1049
1050
1051
1052
…
next ›
last »